Chugai's diagnostics sales rise 22% in new fiscal year
This article was originally published in Clinica
Executive Summary
Japanese pharmaceutical company Chugai has reported diagnostics sales of ¥,600 million ($103 million) for the 12 months to March 1996. This represents a 22% increase compared with the 12 months to December 1994, the only comparable period after a change of year-end to March from December. In its annual report Chugai attributes the strong rise in diagnostics sales to robust demand for DNA probes.